Altium Wealth Management LLC Argenx Se Transaction History
Altium Wealth Management LLC
- $1.39 Billion
- Q2 2022
A detailed history of Altium Wealth Management LLC transactions in Argenx Se stock. As of the latest transaction made, Altium Wealth Management LLC holds 1,417 shares of ARGX stock, worth $751,066. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,417
Previous 1,793
20.97%
Holding current value
$751,066
Previous $565,000
4.96%
% of portfolio
0.04%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding ARGX
# of Institutions
370Shares Held
31.4MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$2.97 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.86 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.31 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.02 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$801 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $29.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...